Ronald K. Chang

893 total citations
20 papers, 512 citations indexed

About

Ronald K. Chang is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Genetics. According to data from OpenAlex, Ronald K. Chang has authored 20 papers receiving a total of 512 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Cellular and Molecular Neuroscience and 5 papers in Genetics. Recurrent topics in Ronald K. Chang's work include Neuroscience and Neuropharmacology Research (7 papers), Receptor Mechanisms and Signaling (6 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (5 papers). Ronald K. Chang is often cited by papers focused on Neuroscience and Neuropharmacology Research (7 papers), Receptor Mechanisms and Signaling (6 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (5 papers). Ronald K. Chang collaborates with scholars based in United States and Singapore. Ronald K. Chang's co-authors include Scott D. Kuduk, Christina N. Di Marco, Mark T. Bilodeau, George D. Hartman, Robert M. DiPardo, Marion Wittmann, William J. Ray, Mark G. Bock, Matthew A. Seager and Charles D. Thompson and has published in prestigious journals such as Journal of Medicinal Chemistry, Psychopharmacology and Tetrahedron Letters.

In The Last Decade

Ronald K. Chang

20 papers receiving 495 citations

Peers

Ronald K. Chang
Christina N. Di Marco United States
Marsha A. McLaughlin United States
Elaine A. Harper United Kingdom
Marc Capet France
Scott C. Mayer United States
Robert J. Altenbach United States
Lawrence A. Black United States
Christina N. Di Marco United States
Ronald K. Chang
Citations per year, relative to Ronald K. Chang Ronald K. Chang (= 1×) peers Christina N. Di Marco

Countries citing papers authored by Ronald K. Chang

Since Specialization
Citations

This map shows the geographic impact of Ronald K. Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald K. Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald K. Chang more than expected).

Fields of papers citing papers by Ronald K. Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald K. Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald K. Chang. The network helps show where Ronald K. Chang may publish in the future.

Co-authorship network of co-authors of Ronald K. Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald K. Chang. A scholar is included among the top collaborators of Ronald K. Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald K. Chang. Ronald K. Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Beshore, Douglas C., Christina N. Di Marco, Ronald K. Chang, et al.. (2018). MK-7622: A First-in-Class M1 Positive Allosteric Modulator Development Candidate. ACS Medicinal Chemistry Letters. 9(7). 652–656. 28 indexed citations
2.
Greshock, Thomas J., John M. Sanders, Robert E. Drolet, et al.. (2016). Potent, selective and orally bioavailable leucine-rich repeat kinase 2 (LRRK2) inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(11). 2631–2635. 15 indexed citations
3.
Uslaner, Jason M., Donnie Eddins, Christopher E. Cannon, et al.. (2012). The muscarinic M1 receptor positive allosteric modulator PQCA improves cognitive measures in rat, cynomolgus macaque, and rhesus macaque. Psychopharmacology. 225(1). 21–30. 57 indexed citations
4.
Kuduk, Scott D., Ronald K. Chang, Thomas J. Greshock, et al.. (2012). Identification of Amides as Carboxylic Acid Surrogates for Quinolizidinone-Based M1 Positive Allosteric Modulators. ACS Medicinal Chemistry Letters. 3(12). 1070–1074. 16 indexed citations
5.
Kuduk, Scott D., Ronald K. Chang, Christina N. Di Marco, et al.. (2011). Identification of non-amidine inhibitors of acid-sensing ion channel-3 (ASIC3). Bioorganic & Medicinal Chemistry Letters. 21(14). 4255–4258. 16 indexed citations
6.
Kuduk, Scott D., Ronald K. Chang, Christina N. Di Marco, et al.. (2011). Quinolizidinone carboxylic acid selective M1 allosteric modulators: SAR in the piperidine series. Bioorganic & Medicinal Chemistry Letters. 21(6). 1710–1715. 20 indexed citations
7.
Kuduk, Scott D., Ronald K. Chang, Christina N. Di Marco, et al.. (2011). Discovery of a Selective Allosteric M1Receptor Modulator with Suitable Development Properties Based on a Quinolizidinone Carboxylic Acid Scaffold. Journal of Medicinal Chemistry. 54(13). 4773–4780. 48 indexed citations
8.
Kuduk, Scott D., Christina N. Di Marco, Ronald K. Chang, et al.. (2010). Heterocyclic fused pyridone carboxylic acid M1 positive allosteric modulators. Bioorganic & Medicinal Chemistry Letters. 20(8). 2533–2537. 21 indexed citations
9.
Kuduk, Scott D., Ronald K. Chang, Christina N. Di Marco, et al.. (2010). Quinolizidinone Carboxylic Acids as CNS Penetrant, Selective M1 Allosteric Muscarinic Receptor Modulators. ACS Medicinal Chemistry Letters. 1(6). 263–267. 58 indexed citations
10.
Kuduk, Scott D., Christina N. Di Marco, Ronald K. Chang, et al.. (2009). Amiloride derived inhibitors of acid-sensing ion channel-3 (ASIC3). Bioorganic & Medicinal Chemistry Letters. 19(9). 2514–2518. 51 indexed citations
11.
Chang, Ronald K., et al.. (2009). Preparation of 4-heteroaryl-4-cyanopiperidines via SNAr substitution reactions. Tetrahedron Letters. 50(46). 6303–6306. 7 indexed citations
12.
Kuduk, Scott D., Ronald K. Chang, Jenny Wai, et al.. (2009). Amidine derived inhibitors of acid-sensing ion channel-3 (ASIC3). Bioorganic & Medicinal Chemistry Letters. 19(15). 4059–4063. 45 indexed citations
13.
Kuduk, Scott D., Ronald K. Chang, Robert M. DiPardo, et al.. (2008). Bradykinin B1 receptor antagonists: An α-hydroxy amide with an improved metabolism profile. Bioorganic & Medicinal Chemistry Letters. 18(18). 5107–5110. 21 indexed citations
14.
Feng, Dong-Mei, Robert M. DiPardo, Jenny Wai, et al.. (2007). A new class of bradykinin B1 receptor antagonists with high oral bioavailability and minimal PXR activity. Bioorganic & Medicinal Chemistry Letters. 18(2). 682–687. 15 indexed citations
15.
Kuduk, Scott D., Robert M. DiPardo, Ronald K. Chang, et al.. (2007). Bradykinin B1 antagonists: Biphenyl SAR studies in the cyclopropanecarboxamide series. Bioorganic & Medicinal Chemistry Letters. 17(13). 3608–3612. 13 indexed citations
16.
Kuduk, Scott D., Christina N. Di Marco, Ronald K. Chang, et al.. (2006). 5-Piperazinyl pyridine carboxamide bradykinin B1 antagonists. Bioorganic & Medicinal Chemistry Letters. 16(10). 2791–2795. 10 indexed citations
17.
Kuduk, Scott D., Ronald K. Chang, Christina Ng, et al.. (2005). Bradykinin B1 antagonists: SAR studies in the 2,3-diaminopyridine series. Bioorganic & Medicinal Chemistry Letters. 15(17). 3925–3929. 14 indexed citations
18.
Chang, Ronald K., Robert M. DiPardo, & Scott D. Kuduk. (2005). Application of the thioimidate cyclopropane rearrangement to heterocyclic synthesis. Preparation of diaryl pyrrolines. Tetrahedron Letters. 46(49). 8513–8516. 8 indexed citations
19.
Kuduk, Scott D., Robert M. DiPardo, Ronald K. Chang, Christina Ng, & Mark G. Bock. (2004). Reversal of diastereoselection in the addition of Grignard reagents to chiral 2-pyridyl tert-butyl (Ellman) sulfinimines. Tetrahedron Letters. 45(35). 6641–6643. 38 indexed citations
20.
Kuduk, Scott D., Christina Ng, Ronald K. Chang, & Mark G. Bock. (2003). Synthesis of 2,3-diaminodihydropyrroles via thioimidate cyclopropane rearrangement. Tetrahedron Letters. 44(7). 1437–1440. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026